Your browser doesn't support javascript.
loading
Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO).
Halpern, Bruno; Mancini, Marcio C; de Melo, Maria Edna; Lamounier, Rodrigo N; Moreira, Rodrigo O; Carra, Mario K; Kyle, Theodore K; Cercato, Cintia; Boguszewski, Cesar Luiz.
Afiliação
  • Halpern B; Centro de Obesidade, Hospital 9 de Julho, São Paulo, SP, Brasil, brunohalpern@hotmail.com.
  • Mancini MC; Grupo de Obesidade e Síndrome Metabólica, Departamento de Endocrinologia e Metabolismo, Universidade de São Paulo, São Paulo, SP, Brasil.
  • de Melo ME; Grupo de Obesidade e Síndrome Metabólica, Departamento de Endocrinologia e Metabolismo, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Lamounier RN; Centro de Diabetes de Belo Horizonte, Belo Horizonte, MG, Brasil.
  • Moreira RO; Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione, Rio de Janeiro, RJ, Brasil.
  • Carra MK; Grupo de Diabetes, Departamento de Endocrinologia, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Kyle TK; ConscienHealth, Pittsburgh, PA, USA.
  • Cercato C; Grupo de Obesidade e Síndrome Metabólica, Departamento de Endocrinologia e Metabolismo, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Boguszewski CL; Presidente Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO), São Paulo, SP, Brasil.
Arch Endocrinol Metab ; 66(2): 139-151, 2022 Apr 28.
Article em En | MEDLINE | ID: mdl-35420271
Obesity is a chronic disease associated with impaired physical and mental health. A widespread view in the treatment of obesity is that the goal is to normalize the individual's body mass index (BMI). However, a modest weight loss (usually above 5%) is already associated with clinical improvement, while weight losses of 10%-15% bring even further benefits, independent from the final BMI. The percentage of weight reduction is accepted as a treatment goal since a greater decrease in weight is frequently difficult to achieve due to metabolic adaptation along with environmental and lifestyle factors. In this document, the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO) propose a new obesity classification based on the maximum weight attained in life (MWAL). In this classification, individuals losing a specific proportion of weight are classified as having "reduced" or "controlled" obesity. This simple classification - which is not intended to replace others but to serve as an adjuvant tool - could help disseminate the concept of clinical benefits derived from modest weight loss, allowing individuals with obesity and their health care professionals to focus on strategies for weight maintenance instead of further weight reduction. In future studies, this proposed classification can also be an important tool to evaluate possible differences in therapeutic outcomes between individuals with similar BMIs but different weight trajectories.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica Tipo de estudo: Guideline Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica Tipo de estudo: Guideline Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article